🌍 Global Infectious Diseases & One Health Conference (GIOH 2026)

Theme: From Breakthroughs to Preparedness: The Next Era of Infectious Diseases

The Global Infectious Diseases & One Health Conference (GIOH 2026) is a premier international event bringing together researchers, healthcare professionals, scientists, policymakers, and industry experts dedicated to advancing infectious disease research and global health strategies.

The conference will take place in London, United Kingdom, with online participation available, allowing professionals worldwide to connect, collaborate, and share knowledge on the latest developments in infectious disease prevention and control.

GIOH 2026 provides a platform to explore emerging pathogens, outbreak preparedness, and innovative public health solutions. The conference emphasizes the One Health approach, recognizing the strong connections between human, animal, and environmental health in combating infectious diseases.

---

📅 Conference Dates & Venue

📅 September 21–23, 2026

📍 London, United Kingdom & Online Participation Available

---

🎓 Continuing Education Benefits

The conference is a CPD Accredited Event designed to support ongoing professional development.

🎓 Earn 15+ CPD Credits

Participants will gain valuable insights into the latest advancements while fulfilling their continuing professional development requirements.

---

⭐ Additional Conference Benefits

👥 Group Registration Savings
Register 3 or more colleagues and receive 20% team discount.

📚 Journal Collaborations
Publish your research in collaborated journals and receive exclusive discounts up to 50% or more.

---

🔬 Scientific Program Highlights

The conference program will include:

• Keynote presentations from global infectious disease experts
• Oral and poster research presentations
• Panel discussions on emerging infectious diseases
• Sessions on outbreak preparedness and response strategies
• Discussions on global health initiatives and policies

---

🧪 Key Topics Covered

Participants will explore areas such as:

• Emerging and re-emerging infectious diseases
• Outbreak preparedness and response strategies
• Zoonotic diseases and the One Health approach
• Advances in infectious disease diagnostics and treatment
• Global health policies and disease surveillance

---

🌍 Join the Global Infectious Disease Community

Whether attending in London or online, GIOH 2026 offers an excellent opportunity to learn from experts, collaborate with peers, and contribute to the future of infectious disease research and public health.

🔗 Register for the Conference
https://infection.miconferences.com/register

🌐 Conference Website
https://infection.miconferences.com/

📧 Email: infection@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

#GIOH2026 #InfectiousDiseases #OneHealth #GlobalHealth #MedicalConference #PublicHealth #HealthcareInnovation #DiseasePrevention

🌍 Global Infectious Diseases & One Health Conference

📚 Explore the Scientific Topics

The Global Infectious Diseases & One Health Conference will bring together leading scientists, researchers, clinicians, and healthcare professionals to discuss the latest developments in infectious disease research and global health.

Our conference features a wide range of scientific topics covering current challenges, innovative technologies, and emerging solutions in infectious disease prevention, diagnosis, and treatment.

🧬 Infectious Disease Research
🦠 Emerging & Re-emerging Infections
💉 Vaccine Development & Immunology
🔬 Molecular Diagnostics & Biosensors
🌎 One Health & Global Health Strategies
🧫 Microbiology & Pathogen Biology
📊 Epidemiology & Public Health

These topics provide a platform for knowledge exchange, collaboration, and scientific advancement among experts from around the world.

📅 Conference Dates: September 21–23, 2026
📍 Venue: London, United Kingdom & Online

📑 Scientific Topics:
https://infection.miconferences.com/program/scientific-topics

#InfectiousDiseases #ScientificResearch #GlobalHealth #OneHealth #MedicalConference #Microbiology #Immunology #PublicHealth #LondonConference #HealthcareInnovation

🌍 Global Infectious Diseases & One Health Conference

📢 First Phase of Abstract Submission Closing Soon!

Researchers, scientists, clinicians, and healthcare professionals are invited to share their latest research at the Global Infectious Diseases & One Health Conference.

⏳ First Phase of Abstract Submission closes on March 12, 2026

Submit your research and present your work to an international audience of experts in infectious diseases, global health, diagnostics, and public health.

🎤 Present your latest findings
🌐 Connect with global experts and researchers
🧬 Showcase innovative research in infectious diseases
🤝 Build international collaborations

📅 Conference Dates: September 21–23, 2026
📍 Venue: London, United Kingdom & Online

📄 Abstract Submission:
https://infection.miconferences.com/abstract-submission

Be part of this global scientific gathering and contribute to advancing research in infectious diseases.

#InfectiousDiseases #GlobalHealth #MedicalConference #AbstractSubmission #OneHealth #MedicalResearch #PublicHealth #LondonConference #HybridConference

🌍 Global Infectious Diseases & One Health Conference

⏳ Early Registration Deadline Approaching!

Don’t miss your chance to join leading researchers, healthcare professionals, and global experts at the Global Infectious Diseases & One Health Conference.

📢 Early Registration closes on March 13, 2026

This international conference will bring together experts to discuss the latest research, innovations, and strategies in infectious disease prevention, diagnostics, treatment, and global health.

🌐 Connect with global researchers
🧬 Explore cutting-edge scientific discoveries
🎤 Participate in expert-led sessions
🤝 Network with professionals from around the world

📅 Conference Dates: September 21–23, 2026
📍 Venue: London, United Kingdom & Online

📝 Register Now: https://infection.miconferences.com/register

Secure your spot today and take advantage of the early registration opportunity before the deadline.

#InfectiousDiseases #GlobalHealth #MedicalConference #OneHealth #HealthcareInnovation #PublicHealth #MedicalResearch #LondonConference #HybridConference #EarlyRegistration

🌍 Global Infectious Diseases & One Health Conference

👩‍🔬 Presenter: Jianghong Wu

🏫 Affiliation: Shenzhen Technology University, China

🎤 Presentation Type: Speaker Presentation

Title: A Smartphone-Assisted Electrochemical Biosensor Platform for Rapid Nucleic Acid Detection ofInfluenza A

---

🦠 Advancing Rapid Detection of Influenza A

Influenza A viruses circulate globally each year and pose a significant threat to public health due to their high transmissibility. Rapid and accurate detection is essential for early intervention and outbreak control.

Traditional diagnostic methods such as Reverse Transcription Polymerase Chain Reaction (RT-PCR) provide excellent analytical performance. However, their dependence on complex instruments and trained professionals limits their use in rapid, on-site testing.

To overcome these challenges, researchers have developed a smartphone-assisted electrochemical biosensor platform designed for sensitive, portable, and rapid detection of Influenza A.

---

📱 Smartphone-Based Biosensor Technology

This innovative sensing platform integrates:

🔬 Screen-printed electrodes (SPEs)
🧲 Magnetic beads with immobilized DNA probes
📱 Smartphone-based signal processing and results display

The system captures and isolates viral nucleic acids while enabling real-time electrochemical detection using portable devices.

---

⚡ Signal Amplification Strategies

To enhance detection sensitivity, methylene blue (MB) is used to intercalate into double-stranded nucleic acid structures and generate measurable electrochemical signals.

Additional amplification strategies include:

🔹 Adding [Fe(CN)₆]³⁻/⁴⁻ electrolyte, increasing signal strength 3 times
🔹 Using Prussian Blue Analogues (PBA) mediator layers, increasing signal strength up to 50 times

The electrochemical responses are recorded through a smartphone-based potentiostat, creating a compact and accessible diagnostic system.

---

📊 High Sensitivity and Rapid Testing

The developed platform demonstrates:

📈 Linear detection range: 0.5 aM – 100 nM
🔍 Detection limit: 2.01 aM
⏱ Test time: Less than 1 hour

This sensitivity is comparable to RT-PCR, yet the method eliminates nucleic acid amplification, simplifying the entire diagnostic process.

---

🚀 Future of Point-of-Care Diagnostics

By combining magnetic bead-assisted nucleic acid capture with portable electrochemical detection, this platform offers a promising solution for next-generation point-of-care testing for infectious diseases.

---

👩‍🔬 Biography

Jianghong Wu is an Associate Professor at Shenzhen Technology University, China, specializing in rapid detection technologies for infectious diseases.

She obtained her PhD in Materials Science and Engineering from Donghua University (2013) and later worked as a postdoctoral researcher at the State Key Laboratory of Chemo/Biosensing and Chemometrics at Hunan University.

Her research focuses on electrochemical biosensors for rapid detection, early diagnosis, and health monitoring, contributing to innovative diagnostic technologies for infectious disease control.

---

🌍 Conference Details

📅 Dates: September 21–23
📍 Venue: London, United Kingdom & Online

🔗 Event Website: https://infection.miconferences.com/
📝 Registration: https://infection.miconferences.com/register

📧 Email: infection@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

#InfectiousDiseases #InfluenzaResearch #Biosensors #PointOfCareTesting #MedicalTechnology #GlobalHealth #Diagnostics #MedicalConference #OneHealth #LondonConference

🌍 Global Infectious Diseases & One Health Conference

Presenter: Michele Mishto

Affiliation: King’s College London, United Kingdom

Presentation Type: Keynote Presentation (In-Person)

Title: Pathogen-derived noncanonical epitopes: are they valuable targets for novel vaccinations?

---

🧬 Exploring Noncanonical Epitopes for Next-Generation Vaccines

Major Histocompatibility Complex (MHC) class I molecules present antigenic peptides derived not only from canonical proteins but also from sequences generated through post-translational mechanisms such as proteasome-generated peptide splicing.

These noncanonical epitopes represent a promising yet underexplored field in infectious disease immunology and vaccine development.

---

🦠 Pathogen-Derived Spliced Peptides in Immune Response

Recent research has focused on identifying pathogen-derived noncanonical epitopes and evaluating their immunogenic potential. Advanced computational pipelines have been developed to:

🔬 Identify canonical pathogen epitopes
🧬 Predict noncanonical epitopes generated by peptide splicing
💉 Evaluate their immunogenicity in infectious diseases
⚕ Explore their therapeutic potential in vaccine development

These tools are expanding the possibilities for designing innovative vaccines against infectious diseases.

---

⚠ Future Perspectives in Vaccine Research

Although pathogen-derived noncanonical epitopes offer promising opportunities, researchers must carefully evaluate the risk of autoimmune responses that could potentially be triggered by these peptides.

Understanding immune balance is crucial for developing safe and effective vaccines.

---

👨‍⚕️ Biography

Prof. Michele Mishto is Professor in Immunobiology at King’s College London and Senior Group Leader at the Francis Crick Institute in London (UK).

He completed his PhD in Medical Biotechnology at the University of Bologna (Italy) and later conducted postdoctoral research at the Institute of Biochemistry at Universitätsmedizin Charité Berlin (Germany).

His research focuses on antigen presentation and proteasome biology, particularly the discovery and characterization of proteasome-generated spliced peptides and their role in immune responses in cancer and infectious diseases.

---

🌍 Conference Details

📅 Dates: September 21–23
📍 Venue: London, United Kingdom & Online

🔗 Website: https://infection.miconferences.com/
📝 Register: https://infection.miconferences.com/register

📧 Email: infection@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

#InfectiousDiseases #Immunology #Vaccines #AntigenPresentation #Proteasome #GlobalHealth #MedicalResearch #OneHealth #LondonConference #MedicalConference

🌍 Global Infectious Diseases & One Health Conference

Presenter: Francis J. Castellino

Affiliation: University of Notre Dame, United States

Presentation Type: Keynote Presentation (In-Person)

Title: Molecular Crosstalk Between the Pathogen and Host in Group A Streptococcal Infections

---

🦠 Understanding Host–Pathogen Interactions in Group A Streptococcal Infections

Group A Streptococcus pyogenes (GAS) infections remain a significant concern in infectious disease research. The innate immune system plays a crucial role in determining the severity and progression of these infections.

Key biological systems involved include:

• 🧬 Hemostasis system
• 🔬 Fibrinolytic pathways
• ⚕ Inflammatory response mechanisms

The infection cascade begins with the activation of the blood coagulation system via the intrinsic (contact) pathway. This pathway interacts closely with inflammatory responses through the release of bradykinin, contributing to immune activation and disease progression.

---

🧫 Role of the Fibrinolytic System in GAS Virulence

Many GAS strains exploit the fibrinolytic system to enhance their virulence. This process occurs when:

• Plasminogen binds to bacterial surface receptors
• It becomes activated to plasmin, a powerful protease
• The bacterial surface becomes proteolytic

This mechanism enables bacteria to penetrate deeper tissue layers and spread infection. As a result, severe complications such as:

• Sepsis
• Necrotizing fasciitis

may develop, demonstrating how GAS manipulates host biological systems to promote infection.

---

👨‍⚕️ Biography
                      
Francis J. Castellino, Ph.D., FAHA, FAAAS, is the Kleiderer-Pezold Professor of Biochemistry and Director of the W.M. Keck Center for Transgene Research at the University of Notre Dame, United States.

He earned his Ph.D. from the University of Iowa and completed postdoctoral training at Duke University. Dr. Castellino joined the University of Notre Dame faculty in 1970 and served as Dean of Science for more than two decades.

His research focuses on hemostasis, inflammation, and disease models exploring the molecular crosstalk between host systems and pathogens. Throughout his distinguished career, he has published more than 500 peer-reviewed scientific articles and mentored over 100 graduate students, postdoctoral fellows, and research trainees.

                                           

---

🌍 Join the Global Infectious Diseases & One Health Conference

📅 Dates: September 21–23
📍 Venue: London, United Kingdom and Online

🔗 Website: https://infection.miconferences.com/
📝 Register: https://infection.miconferences.com/register

📧 Email: infection@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

#InfectiousDiseases #Streptococcus #Microbiology #GlobalHealth #PublicHealth #MedicalResearch #HostPathogenInteraction #Sepsis #NecrotizingFasciitis #LondonConference #MedicalConference #OneHealth

Global Infectious Diseases & One Health Conference

Presenter: Sergey Suchkov

Affiliation: N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Presentation Type: Keynote Presentation (In-Person)

Title: The transformation of Personalized and Precision Medicine (PPM) as a unique healthcare model for infectious diseases monitoring & management

🧬 The Rise of Personalized & Precision Medicine (PPM) in Infectious Diseases

A new and upgraded approach to diseased states and wellness has reshaped modern healthcare into what is now recognized globally as Personalized and Precision Medicine (PPM). This innovative model integrates Fundamental Sciences, Healthcare & Life Sciences, Biodesign-driven Biotechnology, Translational Research, and advanced IT platforms.

PPM enables:

· 🔮 Pre-early predictive diagnostics
· 🎯 Precise prognostication
· 🧬 Personalized therapeutic strategies
· 📊 Integration of large-scale clinical & OMICS databanks
· 💰 More cost-effective healthcare delivery

Rooted in Systems & Synthetic Biology and translational biotechnologies, PPM represents a cornerstone of the emerging national Bioeconomy.

---

🦠 PPM in Infectious Disease Monitoring & Management

Advances in genomics and computational biology are transforming infectious disease preparedness and response. However, precision genomics and immunogenetics are still underutilized in routine infectious disease care.

New technologies now support:

· 🔬 Rapid identification of infectious agents
· 🧬 Detection of antimicrobial resistance profiles
· 💊 Targeted antimicrobial therapy
· 🛡 Personalized prevention strategies
· 📈 Genomic surveillance for outbreak response

PPM concepts allow clinicians to rapidly identify pathogens and determine resistance patterns, ensuring proper antimicrobial treatment—especially for persons-at-risk.

---

⚕ Clinical Microbiology & Genomic Surveillance

Traditional microbiology diagnostics often require more than 24 hours, delaying critical interventions. PPM-driven genomics shortens diagnostic cycles and enhances precision in treatment decisions.

With advances in sequencing speed and affordability, pathogen genome data is now revolutionizing outbreak response and molecular epidemiology—bringing precision infectious disease management into routine practice.

---

🎓 Education & Implementation

Successful implementation of PPM in infectious disease care requires:

· 📚 Next-generation professional education
· 🧑‍⚕️ Genomic literacy among clinicians
· 🏛 Policy and regulatory acceptance
· 💻 Advanced communication & data platforms

PPM-driven infectious disease management strengthens public trust in healthcare systems, science, and pharmaceutical innovation.

---

👨‍⚕️ Biography

Sergey Suchkov completed his graduation from Astrakhan State Medical University (MD). He earned his PhD from I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology.

He currently serves as Professor and Director in Personalized Medicine at I.M. Sechenov First Moscow State Medical University and Department of Clinical Immunology at A.I. Evdokimov Moscow State Medical and Dental University.

He is also Professor and Chair of Translational Medicine at Moscow Engineering Physical Institute, Russia, and Secretary General of the United Cultural Convention, UK.

---

🌍 Join the Global Conversation

Event: Global Infectious Diseases & One Health Conference

📅 Dates: September 21–23
📍 Venue: London, United Kingdom and Online

🔗 Website: https://infection.miconferences.com/
📝 Register: https://infection.miconferences.com/register

📧 Email: infection@mathewsconference.com
📞 Phone: +1 (312) 462-4448
💬 WhatsApp: +1 (424) 377 0967

#PrecisionMedicine #PersonalizedMedicine #InfectiousDiseases #PPM #Genomics #ClinicalMicrobiology #GlobalHealth #PublicHealth #AntimicrobialResistance #HealthcareInnovation #AbstractSubmission #HybridConference #LondonConference

 Global Infectious Diseases & One Health Conference

Call for Abstract Submission & Keynote Spotlight

March 3

📅 Conference Dates: September 21–23
📍 Venue: London, United Kingdom and Online

🔗 Event Website: https://infection.miconferences.com/
📝 Register Here: https://infection.miconferences.com/register
📄 Abstract Submission: https://infection.miconferences.com/abstract-submission
📩 Contact Page: https://infection.miconferences.com/contact

📞 Contact Details:
Email: infection@mathewsconference.com
Phone: +1 (312) 462-4448
WhatsApp: +1 (424) 377 0967

Submit your research through the official Abstract Submission portal and join global experts advancing infectious diseases and One Health research.

#AbstractSubmission #CallForAbstracts #InfectiousDiseases #OneHealth #GlobalConference #MedicalResearch #PublicHealth #HealthcareInnovation #LondonConference #HybridEvent

Global Infectious Diseases & One Health Conference 2026

Keynote Spotlight: A Global Expert Joins the Conference

Keynote Speaker Announcement 🌍

We are delighted to announce that Saim Memon from Sanyou London Pvt Ltd will be delivering a keynote address at the upcoming Global Infectious Diseases & One Health Conference.

📅 Conference Dates: September 21–23, 2026

📍 Venue: London, United Kingdom and Online

🔗 Event Website: https://infection.miconferences.com/

📝 Register Here: https://infection.miconferences.com/register

📞 Contact Details:

Email: infection@mathewsconference.com
Phone: +1 (312) 462-4448
WhatsApp: +1 (424) 377 0967

Join us in London or attend virtually to connect with global experts in infectious diseases and One Health research.

#InfectiousDiseases #OneHealth #GlobalConference #MedicalResearch #HealthcareInnovation #PublicHealth #LondonConference #HybridEvent #CallForAbstracts #Vlog